Guinea pigs lewisite exposure

Analytical Methods for Urine and Blood. Specific biomarkers of lewisite exposure are currently based on a very limited number of in vitro experiments (Jakubowski et al., 1993 Wooten et al., 2002) and animal studies (Logan et al., 1999 Fidder et al., 2000). Wooten et al. (2002) developed a solid-phase microextraction (SPME) headspace sampling method for urine samples followed by GC-MS analysis. It is the most sensitive method reported to date with a lower limit of detection of 7.4 pg/mL. Animal experiments have been limited in number and in their scope. In one study of four animals, guinea pigs were given a subcutaneous dose of lewisite (0.5 mg/kg). Urine samples were analyzed for CVAA using both GC-MS and GC coupled with an atomic emission spectrometer set for elemental arsenic (Logan et al., 1999). The excretion profile indicated a very rapid elimination of CVAA in the urine. The mean concentrations detected were 3.5 pg/mL, 250 ng/mL, and 50 ng/mL for the 0-8, 8-16, and 16-24 h samples, respectively. Trace level concentrations... 

Lewisite bound to haemoglobin cysteine residues is displaced by conversion to the BAL derivative shown in Figure 7 (Fidder et al, 2000). Exposure of guinea pigs to lewisite (0.25 mg/kg, subcutaneous) could be demonstrated by whole blood analysis (i.e. adducts + CVAA) up to at least 240 h. 

---